secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001819790-24-000024
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharmaceuticals completes public offering, raising net proceeds of $107.8M
--------------------------------------------------------------------------------

- Sold 3,281,250 shares and pre-funded warrants for 312,500 shares at $32.00 public price.
- Underwriters exercised option in full to purchase additional 468,750 shares.
- Net proceeds after discounts and expenses were approximately $107.8 million.
- Offering closed March 5, 2024; led by Goldman Sachs, BofA Securities, Guggenheim Securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000024/0001819790-24-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000024/tars-20240305.htm
  HTML page:      https://secwatch.observer/filing/0001819790-24-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer